The authors engineered human MSCs transduced with TRAIL and the IRES-eGFP reporter gene, under the control of a tetracycline promoter using a lentiviral vector, and tested their anti-tumor effect on a lung cancer model. This evidence concerns the gene TNFSF10 and neoplasm.